ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686559 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686559; 2) Community: the network communities that were significantly associated with the response to NSC 686559; 3) Molecule: the relationships between components within communities and NSC 686559; 4) MDR: the compounds that were significantly associated with the NSC 686559.

NSC Compound Enrichment Correlation
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0222343516878698 -0.057692992
NSC 695267 Null 0.0222343516878698 -0.24857627
NSC 697189 Null 0.0222343516878698 0.10336062
NSC 706995 Entinostat 0.0222343516878698 -0.23262995
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0222343516878698 -0.09905295
NSC 734231 2[4'aminobiphenyl]5,6dichlorobenzimidazole 0.0222343516878698 -0.20068785
NSC 756134 GSK1023156A 0.0222343516878698 -0.12903102
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.0244632509325736 -0.047118229
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0244632509325736 -0.096176066
NSC 295501 Camptothecin Derivative 0.0244632509325736 0.056965915
Total:55  Current:25    [First] [Prev] [Next] [Last]